Quick Takeaways
- Nancy Wysenski has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $3,255,756.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Nancy Wysenski and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| CYTK | CYTOKINETICS INC | Director | $2,047,556 | 15 Apr 2026 | ||
| ALKS | Alkermes plc. | Director | $1,208,200 | 07 Jul 2023 | ||
| PRVB | Provention Bio, Inc. | Director | 27 Apr 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|